NBG Volume Alert - NBG 2.18 National Bank of Greece Sa $NBG

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
NBG Volume Alert - NBG 2.18 National Bank of Greece Sa $NBG Hit a high of 2.20 Currently 11:15 Last price 2.18 -0.05 -2.24% With a day low of 2.13 and a current volume of 2,296,221.

NBG National Bank of Greece Sa Recent Headline News

National Bank of Greece's (NBG) CEO Alexandros Tourkolias on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 6:43AM CST

NBG: 2.20 (-0.03)

National Bank of Greece SA reports Q3 earnings
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 6:21PM CST

NBG: 2.20 (-0.03)

National Bank of Greece (NBG) Stock Declines After EBA Chairman's Comments
at The Street - Thu Oct 30, 10:23AM CDT
Shares of National Bank of Greece (NBG) dropped Thursday after European Banking Authority Chairman Andrea Enria suggested last week's stress tests of European banks still left more work to do.
NBG: 2.20 (-0.03)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 8:18AM CDT

KNDI: 15.75 (+0.89), ALU: 3.18 (+0.01), CDTI: 2.49 (-0.15), VSR: 3.06 (+0.03), NBG: 2.20 (-0.03), ARAY: 7.05 (+0.15), GLUU: 3.78 (-0.01), OCLS: 1.81 (+0.02), CEMI: 4.41 (+0.26), TTWO: 26.07 (-0.03), PRXL: 54.74 (+0.24), RDN: 16.62 (+0.14), BBD: 14.21 (+0.03), NVAX: 5.33 (+0.12), APT: 3.06 (-0.05), BBSI: 22.55 (-1.73), LAKE: 12.86 (-0.12), GOL: 4.83 (+0.02), TASR: 19.42 (+0.49), AUY: 3.86 (+0.20), PCRX: 87.24 (-0.59), ITUB: 13.99 (-0.12)

National Bank of Greece continues slide
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 2:32PM CDT

GREK: 15.34 (-0.07), NBG: 2.20 (-0.03)

80% ECB Banks Pass Stress Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 9:55AM CDT
European banks emerged as healthier. Of 123 banks that were part of the stress test, only 24 failed to meet the minimum common equity ratio (CET1) level of 5.5%.
BCS: 14.92 (+0.05), SAN: 8.41 (+0.11), HSBC: 50.58 (+0.21), DB: 30.12 (+0.12), NBG: 2.20 (-0.03), RBS: 12.02 (+0.04), LYG: 4.83 (unch)


13 Europe banks flunk test, must find 10B euros
By DAVID McHUGH - AP - Sun Oct 26, 3:00PM CDT
FRANKFURT, Germany (AP) — The European Central Bank says 13 of Europe's 130 biggest banks have flunked an in-depth review of their finances and need an extra 10 billion euros ($12.5 billion) to cushion themselves against any future crises.
NBG: 2.20 (-0.03)


A look at European banks that flunked test
The Associated Press - AP - Sun Oct 26, 9:59AM CDT
FRANKFURT, Germany (AP) — A total of 13 European banks have been asked to strengthen their finances after a broad review of their books.
NBG: 2.20 (-0.03)

Review on Diversified Banks Stocks - US Bancorp, Banco Santander Brasil, Banco Santander, National Bank of Greece, and Comerica
PR Newswire - Fri Oct 24, 8:10AM CDT
Investor-Edge has initiated coverage on the following equities: US Bancorp (NYSE: USB), Banco Santander Brasil S.A. (NYSE: BSBR), Banco Santander S.A. (NYSE: SAN), National Bank of Greece S.A. (NYSE: NBG), and Comerica Inc. (NYSE: CMA). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, October 23, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 16,677.90, up 1.32% and the NASDAQ Composite closed at 4,452.79, up 1.60%. The S&P 500 finished the session 1.23% higher at 1,950.82. During the trading session, eight out of ten sectors finished on a higher note. The S&P 500 Financials Sector Index ended the day at 308.34, up 0.98%, with the index advancing 4.62% on YTD basis. Register for your complimentary reports on these five stocks at:
SAN: 8.41 (+0.11), USB: 44.12 (+0.19), NBG: 2.20 (-0.03), CMA: 48.48 (+0.07), BSBR: 5.50 (-0.06)

Europe rebounds on leak of ECB support for Greece
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 9:11AM CDT

FEZ: 37.90 (+0.23), GREK: 15.34 (-0.07), NBG: 2.20 (-0.03)

Greek stocks plunge as bond yields soar
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 11:56AM CDT

GREK: 15.34 (-0.07), NBG: 2.20 (-0.03)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 11:47AM CDT

NPD: 1.76 (unch), IMDZ: 29.39 (-0.76), BCRX: 10.95 (-0.21), DLHC: 2.78 (+0.04), SWSH: 2.75 (-0.12), VSR: 3.06 (+0.03), PPHM: 1.49 (+0.01), EVRY: 0.96 (-0.11), DYNT: 3.96 (+0.06), NBG: 2.20 (-0.03), AMDA: 1.39 (+0.03), TRCH: 1.47 (-0.01), KTCC: 8.68 (-0.07), APT: 3.06 (-0.05), SHPG: 201.81 (+0.83), PENX: 18.78 (-0.02), LAKE: 12.86 (-0.12), MSLI: 1.48 (-0.03), COVS: 2.80 (+0.21)

Investors look to Lighten Up on Shares of National Bank of Greece, Shares Down 8.4% (NBG)
Comtex SmarTrend(R) - Wed Oct 15, 10:07AM CDT
National Bank of Greece (NYSE:NBG) is one of today's worst performing low-priced stocks, down 8.4% to $2.35 on 1.3x average daily volume. National Bank of Greece has traded 5.3 million shares thus far today, vs. average volume of 4.0 million shares per day. The stock has underperformed the Dow (-8.4% to the Dow's -1.2%) and underperformed the S&P 500 (-8.4% to the S&P's -1.2%) during today's trading.
NBG: 2.20 (-0.03)

National Bank of Greece Down 5.4%, Shares Slide into the Red (NBG)
Comtex SmarTrend(R) - Tue Oct 07, 11:36AM CDT
National Bank of Greece (NYSE:NBG) is one of today's worst performing low-priced stocks, down 5.4% to $2.63 on 1.4x average daily volume. National Bank of Greece has traded 5.4 million shares thus far today, vs. average volume of 3.9 million shares per day. The stock has underperformed the Dow (-5.4% to the Dow's -0.6%) and underperformed the S&P 500 (-5.4% to the S&P's -0.5%) during today's trading.
NBG: 2.20 (-0.03)

3 Stocks Driving The Financial Sector Higher
at The Street - Tue Sep 30, 12:04PM CDT
TheStreet highlights 3 stocks pushing the financial sector higher today.
RY: 72.30 (+0.67), RBS: 12.02 (+0.04), NBG: 2.20 (-0.03)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 98

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 0

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

VENU Embraces Blockchain: A New Era for Live Events

Updated Category News Views 203

VENU's Groundbreaking Blockchain Initiative in Live Entertainment In a significant move that signals the future of live entertainment, VENU (NYSE American: VENU), a leading operator of premium venues across the country, has announced an innovative blockchain-powered platform set to launch in 2026. This strategy is revolutionary, intending to blend physical experiences...

Continue Reading
Empowering Leadership Transitions at Ora Enhance Customer Focus

Updated Category News Views 144

Empowering Strategic Leadership at Ora Ora, an esteemed player in the field of ophthalmic contract research organizations (CROs), has recently appointed Cindy Markham as its new Chief Commercial Officer. This strategic move underscores Ora's dedication to enhancing the customer experience, setting a new benchmark in the ophthalmic research sector. Commitment to Customer...

Continue Reading
Real Matters Announces Online Annual General Meeting Details

Updated Category News Views 166

Virtual Annual General Meeting Scheduled for Shareholders Real Matters Inc., a prominent network management services provider, has announced the date for its upcoming Annual General Meeting (AGM). The meeting is set to take place on a Thursday morning, providing a convenient option for shareholders to participate from the comfort of their homes. Accessing the AGM Online...

Continue Reading
Trinity Biotech Triumphs in Nasdaq Compliance Journey

Updated Category News Views 41

Trinity Biotech Celebrates Nasdaq Compliance Achievement Trinity Biotech plc (Nasdaq Global Select: TRIB), a leading name in biotechnology focused on human diagnostics and diabetes management solutions, including innovative wearable biosensors, has reached a significant milestone. The company recently announced it has regained compliance with the minimum market value of...

Continue Reading
Vaycaychella Transitions to Great Estate Blockchains Inc

Updated Category News Views 176

Vaycaychella Unveils a Bold New Identity Vaycaychella, Inc. (OTC Pink: VAYK) has officially announced a name change to "Great Estate Blockchains Inc." This transition signifies a rejuvenated focus on enhancing the value of historic landmarks through innovative cryptocurrency strategies. The company aims to tap into a colossal market, potentially valued in the hundreds of...

Continue Reading